Mar 06, 2018
Aytu BioScience Announces Closing of $12,000,000 Public Offering
Mar 01, 2018
Aytu BioScience Announces Pricing of $12,000,000 Public Offering
Feb 21, 2018
Aytu BioScience Provides Update on the Continued Growth of Natesto® in the U.S.
Feb 08, 2018
Aytu BioScience Provides Fiscal Second Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET
Feb 01, 2018
Aytu BioScience to Report Fiscal Second Quarter 2018 Results and Business Update
Jan 02, 2018
Aytu BioScience to Present at Biotech Showcase 2018 Investor Conference
Dec 18, 2017
Aytu BioScience Announces Appointment of David Green as Chief Financial Officer
Nov 28, 2017
Aytu BioScience Provides Update on the Continued Growth of Natesto® in the U.S.
Nov 09, 2017
Aytu BioScience Provides Fiscal First Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET
Nov 07, 2017
Aytu BioScience Receives Market Approval from the Australian Therapeutic Goods Administration for the MiOXSYS® System for Male Infertility
Nov 02, 2017
Aytu BioScience to Report Fiscal First Quarter 2018 Results and Business Update
Nov 01, 2017
Aytu BioScience Presents Clinical Findings for its MiOXSYS® System at 73rd Annual Meeting of the American Society of Reproductive Medicine
Oct 26, 2017
Aytu BioScience Provides Quarterly Update on the Natesto® U.S. Launch
Oct 19, 2017
Aytu BioScience to Ring The NASDAQ Closing Bell Friday, October 20, 2017
Oct 18, 2017
Aytu BioScience Announces Uplisting to The NASDAQ Capital Market
Oct 09, 2017
Aytu BioScience Corporate Presentation is Now Available for On-Demand Viewing
Oct 03, 2017
Aytu BioScience Announces International Distribution Agreement for Fiera® in Japan
Sep 28, 2017
Aytu BioScience Common Stock Resumes Trading under Symbol 'AYTU' Today
Sep 26, 2017
Aytu BioScience Provides Update on the Natesto® U.S. Launch
Sep 20, 2017
Aytu BioScience to Present at 2017 BioPharm America Conference